Login
$AZTA
$47.22 +$1.57 (3.44%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Martin Madaus Also a director
Interim CEO
Title from the Form 4 dated Oct 22, 2026
66 Not stated Not stated Not reported
Lawrence Lin
EVP, CFO and Treasurer
Title from the Form 4 dated Nov 12, 2026
48 Since 2024
2 years
2024 $3,909,752
Ephraim Starr
Senior Vice President, General Counsel and Secretary
54 Since 2025
1 year
2025 Not reported
Olga Pirogova
Senior Vice President and Chief Human Resources Officer
51 Since 2023
3 years
2023 Not reported
Erik J. Bello
VP Chief Accounting Officer
Title from the Form 4 dated Sep 15, 2026
Not stated Not stated Not stated Not reported
William “Trey” E. Martin III
President Multiomics
Title from the Form 4 dated Sep 14, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Dec 18, 2025 · updated by the 8-Ks of Feb 2, 2026, Aug 24, 2026, and Sep 17, 2026

Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
3.0 years
from year joined
CEO also chairs the board
No
Frank E. Casal
Director Age On board Independent Committees Other public boards 2025 pay Source
Frank E. Casal
71 2021
4 years
Independent
Audit · Chair
None stated $404,765
John P. Marotta
46 2024
1 year
Not independent
Value Creation
None stated Paid as CEO
William L. Cornog
61 2024
1 year
Independent
Value Creation · Chair
Brightview Holdings Inc. (NYSE: BV) $288,873
Robyn C. Davis
64 2013
12 years
Independent
Human Resources and Compensation · Chair
Psychemedics Corporation $303,187
Quentin G. Koffey
48 2024
1 year
Independent
Human Resources and Compensation
Masimo Corporation (NASDAQ: MASI) $289,498
Martin Madaus
66 2024
1 year
Independent None stated Repligen Corporation (NASDAQ: RGEN) $295,123
Erica J. McLaughlin
49 2020
5 years
Independent
Environmental, Social and Governance · Chair
None stated $301,373
Tina S. Nova
72 2023
2 years
Independent
Environmental, Social and Governance
Exagen, Inc. (NASDAQ: XGN) $293,248
Dipal Doshi
50 2025
this year
Independent
Audit
Entrada Therapeutics (NASDAQ: TRDA) $267,623

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Dec 18, 2025 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support